Back
Actinium Pharmaceuticals Vs. SELLAS Life Sciences Group Industry Stock Comparison
Sell
24
ATNM
Actinium Pharmaceuticals
Last Price:
6.97
Seasonality Move:
0.26%
Sell
32
SLS
SELLAS Life Sciences Group
Last Price:
1.20
Seasonality Move:
-14.16%
Sell
24
Actinium Pharmaceuticals (ATNM)
is a Sell
Is Actinium Pharmaceuticals a Buy, Sell or Hold?
- The current Actinium Pharmaceuticals [ATNM] share price is $6.97. The Score for ATNM is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- ATNM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
32
SELLAS Life Sciences Group (SLS)
is a Sell
Is SELLAS Life Sciences Group a Buy, Sell or Hold?
- The current SELLAS Life Sciences Group [SLS] share price is $1.21. The Score for SLS is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- SLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATNM Stock Price Chart
What is Actinium Pharmaceuticals's stock price today?
-
The Actinium Pharmaceuticals share price today is $6.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing slight selling pressure.
SLS Stock Price Chart
What is SELLAS Life Sciences Group's stock price today?
-
The SELLAS Life Sciences Group share price today is $1.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLS is experiencing slight buying pressure.
ATNM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.31 | Sell |
Relative Strength Index (14 RSI): | 36.82 | Sell |
Chaikin Money Flow: | -26939 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.29 - 8.11) | Sell |
Bollinger Bands (100): | (6.93 - 8.89) | Sell |
SLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 46.06 | Sell |
Chaikin Money Flow: | 187756 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.16 - 1.44) | Sell |
Bollinger Bands (100): | (1.04 - 1.46) | Sell |
ATNM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.22 | Sell |
20-day SMA: | 7.58 | Sell |
50-day SMA: | 8.12 | Sell |
200-day SMA: | 6.6 | Buy |
8-day EMA: | 7.23 | Sell |
20-day EMA: | 7.54 | Sell |
50-day EMA: | 7.84 | Sell |
200-day EMA: | 7.32 | Sell |
SLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.16 | Buy |
20-day SMA: | 1.27 | Sell |
50-day SMA: | 1.34 | Sell |
200-day SMA: | 1.12 | Buy |
8-day EMA: | 1.18 | Buy |
20-day EMA: | 1.24 | Sell |
50-day EMA: | 1.28 | Sell |
200-day EMA: | 1.29 | Sell |
Actinium Pharmaceuticals Earnings Growth & ATNM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.51 per share, an increase this year of $0.47 per share, and an increase next year of $1.18 per share.
SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.04 per share, an increase this year of $0.40 per share, and an increase next year of $0.09 per share.
Actinium Pharmaceuticals Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
SELLAS Life Sciences Group Technical Analysis
Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |